These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 2107058

  • 1. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
    Brache V, Alvarez-Sanchez F, Faundes A, Tejada AS, Cochon L.
    Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
    [Abstract] [Full Text] [Related]

  • 2. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 3. Estradiol plasma levels during long-term treatment with Norplant subdermal implants.
    Croxatto HB, Díaz S, Pavez M, Brandeis A.
    Contraception; 1988 Oct; 38(4):465-75. PubMed ID: 3145171
    [Abstract] [Full Text] [Related]

  • 4. Hormonal changes associated with bleeding during low dose progestogen contraception delivered by Norplant subdermal implants.
    Faúndes A, Alvarez-Sanchez F, Brache V, Jimenez E, Tejada AS.
    Adv Contracept; 1991 Mar; 7(1):85-94. PubMed ID: 1908178
    [Abstract] [Full Text] [Related]

  • 5. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM, Segal S, Salem HT, Ghaneimah SA, Khalifa EA, Ahmed AG.
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [Abstract] [Full Text] [Related]

  • 6. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD, Taylor RN, Klaisle C, Bottles K, Zaloudek C.
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [Abstract] [Full Text] [Related]

  • 7. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B, Zeng T, Wu S, Sun H, Xiao N.
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [Abstract] [Full Text] [Related]

  • 8. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use.
    Alvarez F, Brache V, Tejada AS, Faúndes A.
    Contraception; 1986 Feb; 33(2):111-9. PubMed ID: 3084166
    [Abstract] [Full Text] [Related]

  • 9. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
    Croxatto HB, Diaz S, Pavez M, Miranda P, Brandeis A.
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
    [Abstract] [Full Text] [Related]

  • 10. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
    Alvarez F, Brache V, Faundes A, Tejada AS, Thevenin F.
    Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
    [Abstract] [Full Text] [Related]

  • 11. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

  • 12. Norplant implants: the mechanism of contraceptive action.
    Segal SJ, Alvarez-Sanchez F, Brache V, Faundes A, Vilja P, Tuohimaa P.
    Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
    [Abstract] [Full Text] [Related]

  • 13. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W, Reinprayoon D, Pruksananonda K, Niruttisard S, Triratanachat S, Leepipatpaiboon S, Wannakrairot P.
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [Abstract] [Full Text] [Related]

  • 14. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effect of postovulatory administration on ovarian function and endometrium.
    Ling WY, Wrixon W, Zayid I, Acorn T, Popat R, Wilson E.
    Fertil Steril; 1983 Mar; 39(3):292-7. PubMed ID: 6402387
    [Abstract] [Full Text] [Related]

  • 15. Immediate postpartum insertion of the norplant contraceptive device.
    Molland JR, Morehead DB, Baldwin DM, Castracane VD, Lasley B, Bergquist CA.
    Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
    [Abstract] [Full Text] [Related]

  • 16. Endometrial angiogenic response in Norplant users.
    Subakir SB, Hadisaputra W, Handoyo AE, Affandi B.
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL, Affandi B, Rogers PA.
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [Abstract] [Full Text] [Related]

  • 18. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
    Landgren BM, Diczfalusy E.
    Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
    [Abstract] [Full Text] [Related]

  • 19. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM, Elwan SI, el-Kabsh MY, Farghaly SA, Thabet N.
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [Abstract] [Full Text] [Related]

  • 20. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB, Hadisaputra W, Siregar B, Irawati D, Santoso DI, Cornain S, Affandi B.
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.